Table 3 Baseline patient characteristics (N = 28)
Characteristic | Mean (± standard deviation) | N (%) |
|---|---|---|
Age, years | 54.1 (10.2) | Â |
Race/ethnicity | Caucasian | 13 (45) |
Asian | 1 (7) | |
Hispanic | 9 (30) | |
African American | 2 (8) | |
Other | 3 (10) | |
Tobacco use | Never | 14 (50) |
Current | 1 (5) | |
Past | 13 (45) | |
Marital status | Married | 23 (80) |
Single/divorced | 4 (15) | |
Widowed | 1 (5) | |
Education level | High school or equivalent | 10 (35) |
College or postgraduate degree | 15 (55) | |
Other | 3 (10) | |
Employment status | Full-time | 16 (60) |
Part-time | 6 (20) | |
Retired | 6 (20) | |
Cancer stage | I | 11 (40) |
II | 14 (50) | |
III | 3 (10) | |
Surgery type | Mastectomy | 13 (45) |
Lumpectomy | 10 (35) | |
N/A (neoadjuvant chemo) | 5 (20) | |
Chemotherapy type | Doxorubicin/cyclophosphamide + paclitaxel | 13 (42) |
Docetaxel/cyclophosphamide | 11 (36) | |
Carboplatin + paclitaxel | 2 (9) | |
Doxorubicin/cyclophosphamide | 1 (7) | |
Docetaxel/cyclophosphamide/trastuzumab | 1 (6) | |
Diabetes status | Free from disease | 4 (15) |
Pre-diabetic | 18 (64) | |
Diabetic | 6 (21) |